Garza Treviño et al. (63) and Lu et al. (64) indicated that eNOS is upregulated in human mesenchymal CRC tumors and may represent an active stem-cell regulatory point in cancer and a possible target for therapy against aggressive human tumors (63, 64). The gene discussed is NOS3; the disease is colorectal carcinoma.